About Saffron Formulations
Saffron Formulations is a Healthcare company based in Ahmedabad (India) founded in 2013. Pharmaceutical formulations and product development in therapeutic segments like gastro, respiratory, and nutrition. The company has 529 employees. Its Indian entity Saffron Formulations Private Limited reported revenue of ₹60.55 Cr. Saffron Formulations offers products and services including Cardiac Formulations and Gastrointestinal Drugs. Its focus areas include Pharmaceuticals, Drug Development, Formulations and Nutritional Supplements.
Company details
Saffron Formulations Private Limited was established in 2015 in Ahmedabad, Gujarat, as a pharmaceutical company committed to developing and marketing products for key therapeutic segments such as gastroenterology, otolaryngology, respiratory, anti-infectives, nutrition, and pain management. Quality and safety are emphasized alongside innovation, with products offered in categories including cardiac, central nervous system, and renal treatments. The company has been recognized for its rapid growth and entry into elite rankings, aiming to advance healthy lives globally through effective pharmaceutical solutions.
- Headquarters Ahmedabad, India
- Employees 529
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Social LinkedIn Facebook Instagram
- Legal Name Saffron Formulations Private Limited
- Date of Incorporation 21 May, 2015
- Jurisdiction Ahmedabad, Gujarat, India
- Annual Revenue₹60.55 Cr
FY 2025 · +16% YoY
- Net Profit₹50.7 Lakh
FY 2025 · 1% margin
- EBITDA₹3.29 Cr
FY 2025 · 5% margin
- Employee Count529
Associated legal entities of Saffron Formulations
Saffron Formulations operates through Saffron Formulations Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Saffron Formulations Private Limited CIN U74120GJ2015PTC083277 | Active | 21 May 2015 | Ahmedabad, Gujarat | ₹60.6 Cr | 529 | 2 | View details |
Products & Services of Saffron Formulations
Saffron Formulations offers a comprehensive portfolio of products and services, including Cardiac Formulations and Gastrointestinal Drugs.
Cardiac formulations are developed for treating hypertension and related conditions in various therapeutic applications.
Gastrointestinal drugs are provided for managing ulcers, digestive enzymes, and related disorders in clinical settings.
Board of directors of Saffron Formulations Private Limited (Saffron Formulations)
Saffron Formulations Private Limited is the primary company behind Saffron Formulations. The board of Saffron Formulations Private Limited currently have 2 directors; the longest-serving is Amit Singh, appointed in 2015.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Amit Singh DIN 06892570 | Director | 21 May 2015 | 11 yrs 5 mo | Saffron Formulations Private Limited |
| Hiren Rameshchandra Patel DIN 06903021 | Director | 21 May 2015 | 11 yrs 5 mo | Saffron Formulations Private Limited |
Financials of Saffron Formulations
Figures of Saffron Formulations Private Limited, the primary company behind Saffron Formulations, for FY 2025. Revenue was ₹60.55 Cr (+16% year on year). Net profit was ₹50.7 Lakh (1% margin). EBITDA was ₹3.29 Cr (5% margin). Revenue has grown at a compounded annual rate of +25% over three years and +13% over five years.
- ₹60.55 CrRevenue · FY 2025 · +16% YoY
- ₹50.7 LakhNet profit · 1% margin
- ₹3.29 CrEBITDA · 5% margin
- ₹75 LakhPaid-up capital
- 529Employees (provident fund records)
- +25%Revenue CAGR, 3 years
- +13%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Saffron Formulations Private Limited are on its company page.
Detailed financial statements for Saffron Formulations
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Saffron Formulations
Saffron Formulations was founded in 2013.
Saffron Formulations is headquartered in Ahmedabad, India. It is registered at Ahmedabad, Gujarat, India.
Saffron Formulations has 529 employees.
The primary company behind Saffron Formulations, Saffron Formulations Private Limited, reported revenue of ₹60.55 Cr for FY 2025, up 16% year on year.
Saffron Formulations Private Limited was established in 2015 in Ahmedabad, Gujarat, as a pharmaceutical company committed to developing and marketing products for key therapeutic segments such as gastroenterology, otolaryngology, respiratory, anti-infectives, nutrition, and pain management. Quality and safety are emphasized alongside innovation, with products offered in categories including cardiac, central nervous system, and renal treatments. The company has been recognized for its rapid growth and entry into elite rankings, aiming to advance healthy lives globally through effective pharmaceutical solutions.
Saffron Formulations offers Cardiac Formulations and Gastrointestinal Drugs.
Saffron Formulations operates through Saffron Formulations Private Limited.
The legal entities of Saffron Formulations currently have 2 directors, including Amit Singh, Hiren Rameshchandra Patel.